文献速递口腔修复与种植

LNP递送mRNA编码BMP-2增强钛种植体骨整合的体内实验研究

Enhancing Osseointegration With LNP-Delivered mRNA-Encoded BMP-2: An Experimental In Vivo Study.
PubMed 文献 · Clin Oral Implants Res · 2025-10-20

本研究在大鼠股骨缺损模型中评估脂质纳米颗粒包裹的N1-甲基伪尿苷修饰mRNA编码BMP-2(BMP-2 mRNA-LNP)对钛种植体周围骨再生与骨整合的促进作用。48个大鼠股骨随机单次注射5μg或15μg BMP-2 mRNA-LNP、4μg重组人BMP-2蛋白或dPBS,3周和6周时通过micro-CT、组织学与免疫组化评估。结果显示mRNA组骨形成呈增强趋势,15μg组6周时与dPBS组差异显著,5μg和15μg组6周组织形态计量骨面积均显著高于rhBMP-2和dPBS组。

要点

  • BMP-2 mRNA-LNP在大鼠股骨钛植入模型中显示促进种植体周围骨再生的潜力。
  • 15μg BMP-2 mRNA-LNP组6周时micro-CT骨参数与dPBS组差异显著(p<0.05)。
  • 5μg和15μg mRNA-LNP组6周组织形态计量骨面积显著高于rhBMP-2和dPBS组。

核心结论

  • 这项临床前研究提示BMP-2 mRNA-LNP具有促进牙种植体周围骨再生的潜力。

研究设计与样本

  • 研究共检查48个大鼠股骨,随机单次注射BMP-2 mRNA-LNP(5μg和15μg)、重组人BMP-2蛋白(4μg)或dPBS对照(n=6),并植入钛丝。
  • 于治疗后3周和6周采用micro-CT、组织学和免疫组化分析评估骨形成。
  • 数据采用Kruskal-Wallis检验,随后Dunn-Bonferroni检验和Wilcoxon符号秩检验,报告95%CI,p<0.05为有统计学意义。

主要发现

  • 两个时间点micro-CT的骨体积、骨体积分数、骨小梁数量、骨小梁厚度和骨-种植体接触显示mRNA组较其他组有更大骨形成的趋势。
  • 15μg BMP-2 mRNA-LNP组与dPBS组在6周时观察到显著差异(p<0.05)。
  • 15μg BMP-2 mRNA-LNP组在3周和6周分别显示最强的骨唾液蛋白和骨钙素阳性染色。
  • 6周组织形态计量显示5μg和15μg BMP-2 mRNA-LNP组种植体周围骨面积显著高于rhBMP-2和dPBS组。

临床怎么用

  • 结果为临床前证据,尚不能直接转化为口腔种植临床用药方案或剂量推荐。

局限性

  • 研究为大鼠股骨缺损模型,非口腔颌骨或种植临床场景,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the effect of lipid nanoparticle (LNP)-encapsulated N1-methylpseudouridine-modified mRNA encoding BMP-2 (BMP-2 mRNA-LNP) on enhancing osseointegration and bone regeneration around titanium implants in rat femur defects. METHODS: A total of 48 rat femurs were examined in this study. BMP-2 mRNA-LNP (5 μg and 15 μg), recombinant human BMP-2 protein (4 μg), or dPBS (control) were randomly injected in a single dose into distal rat femurs (n = 6). Titanium wires were implanted, and bone formation was evaluated at 3 and 6 weeks post treatment using micro-computed tomography, histology, and immunohistochemistry analysis. Data were analyzed using the Kruskal-Wallis test, followed by the Dunn-Bonferroni test and the Wilcoxon signed-rank test with 95% confidence intervals (CIs). p-values < 0.05 were considered statistically significant. RESULTS: Micro-computed tomography analysis of bone volume, bone volume fraction, trabecular number, trabecular thickness, and bone-to-implant contact at both time points indicated a trend toward greater bone formation in the mRNA groups compared to the other groups. Significant differences were observed between the 15 μg BMP-2 mRNA-LNP group and the dPBS group at 6 weeks (p < 0.05). The 15 μg BMP-2 mRNA-LNP group also exhibited the most intense positive bone sialoprotein and osteocalcin staining compared to the other groups at 3 weeks and 6 weeks, respectively. Interestingly, histomorphometry at 6 weeks revealed a significantly higher bone area around the implants in both 5 μg and 15 μg BMP-2 mRNA-LNP groups compared to the rhBMP-2 and dPBS groups. CONCLUSION: This preclinical study highlights the potential of BMP-2 mRNA-LNP for promoting bone regeneration around dental implants.

来源:Clin Oral Implants Res,查看原文。版权归原作者所有。

引用

  1. Lawtrakulngam N, Vivatbutsiri P, Mahanonda R, et al. Enhancing Osseointegration With LNP-Delivered mRNA-Encoded BMP-2: An Experimental In Vivo Study. Clin Oral Implants Res. 2025. PMID: 41115145. doi:10.1111/clr.70057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。